This week’s topics include advance directive impact, approval of high risk medical devices by FDA, maintenance of certification for physicians, and cardiovascular disease impact of a new agent for type 2 diabetes.

Program notes:

0:37 Positive impact of advance directives

1:34 78% died in their chosen location

2:34 Achieving what the patient wants with regard to care

3:02 Maintenance of certification for physicians

4:02 Randomly assigned to open book and time periods

5:03 Evidence based medicine changes

5:22 New agent for type 2 diabetes and outcomes

6:22 Lowered risk by 14%

7:22 Two times higher risk of amputation

7:40 What about FDA approval of devices

8:40 Premarket approval for new devices

9:40 Hold for months or years and deprive patients?

10:38 End

Podden och tillhörande omslagsbild på den här sidan tillhör Johns Hopkins Medicine. Innehållet i podden är skapat av Johns Hopkins Medicine och inte av, eller tillsammans med, Poddtoppen.